Valgen Medtech

About Valgen Medtech

Valgen Medtech, established in 2015, is a medical technology company focused on developing interventional treatments for structural heart diseases. The company was founded by Dinova Medical Group, which was co-founded by Michael Yiwei Zhao and Eric Zi. Michael Zhao has over two decades of general management experience at multinational medical technology corporations, including Johnson & Johnson Medical's Cordis Corporation, and was instrumental in the IPO and growth of Lifetech Scientific. Eric Zi has nearly 20 years of R&D and operational experience in the implantable medical device industry and was a key designer of China's first-generation PTCA balloon, coronary stent, and other critical devices. The company is headquartered in Hangzhou, China, with an R&D center in Shenzhen and office and manufacturing space covering nearly 10,000 square meters.

Valgen Medtech operates in the global medical device market, with a primary focus on providing solutions for mitral and tricuspid valve diseases to its client base of hospitals and clinics. The company's business model revolves around the research, development, manufacturing, and commercialization of its medical devices. Revenue is generated through the sale of these products. A significant milestone for the company was the completion of a Series B financing round in April 2021, raising a substantial amount for technological innovation and product development. Valgen Medtech has also entered into a strategic marketing cooperation with Venus Medtech to leverage their extensive sales network covering nearly 500 hospitals in China.

The company's core product is the DragonFly™ Transcatheter Mitral Valve Repair System, the first domestically developed transfemoral transcatheter edge-to-edge mitral valve repair device to be approved by China's NMPA (National Medical Products Administration). This device is designed for patients with mitral regurgitation, offering a less invasive treatment option, particularly for high-risk and elderly patients, which can lead to shorter hospital stays and recovery times. The DragonFly™ system features four clip sizes, independent grasping capabilities, and adjustable clipping angles to accommodate a wide range of patient anatomies. In addition to the DragonFly™, Valgen Medtech's product portfolio includes the Pu Jie Jie™ Medical Radiation Protective Shield, the Magpie™ Balloon Dilatation Catheter, and the DragonPath™ Transseptal Puncture System. The company has received numerous accolades, including being named a "Chinese Unicorn Enterprise" in 2020.